Wanders, R
This typically involves: Intrinsic factor antibodies (highly specific for pernicious anaemia, though sensitivity is only 50%) [12] [28] Gastric parietal cell antibodies (more sensitive but less specific) Coeliac serology if malabsorption is suspected Consideration of upper gastrointestinal endoscopy in selected cases, particularly with autoimmune gastritis/pernicious anaemia NICE guidance emphasises that treatment should not be delayed whilst awaiting antibody results if clinical features strongly suggest deficiency, as irreversible neurological damage can occur
Contrarily, macro/microscopic, ultrasonic, magnetic resonance, biomechanical, and functional assessments revealed that BPC 157 therapy recovering effects for all time points were consistent
CJC-1295 CJC-1295 is a growth hormone releasing hormone (GHRH) analog commonly studied for its effects on growth hormone signaling pathways and endocrine regulation mechanisms
Research peptides referenced on PeptideStack are intended for in-vitro laboratory research only and are not presented as treatments, prescriptions, or instructions for human use
